Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium for prevention of cisplatin-induced nephrotoxicity
IRCT138901213678N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of selenium in acute kidney failure (AKF) and Cisplatin-Induced Nephropathy, sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Prevention of cisplatin-induced nephrotoxicity. Started Feb 2010; status: completed.
02
Drugs
selenium
03
Conditions
acute kidney failure (AKF)Cisplatin-Induced Nephropathy
Beyond the preview
Go deeper on IRCT138901213678N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138901213678N1.